Reactive Robotics GmbH is on track

Press |

Successful second investment round

Clinical validation, market entry in Germany and further countries secured by second investment round with existing and new investors

Founded in 2015 in Munich, Reactive Robotics GmbH is a medical device start-up with the corporate objective to provide the best possible Very Early Mobilization (VEM) to intensive care patients as early as 24 hours after hospital admission, directly in the patient’s bed. Amongst experts, VEM is regarded as one of the key factors contributing to the faster recovery of patients.

Reactive Robotics is developing an intelligent therapy device that replaces burdensome manual VEM therapy with an effective, easy and time-efficient robotic solution, enabling care takers and therapists to focus their time and energy on the patients.

Therapy that is currently only possible with enormous physical efforts by care takers and therapists should – with the help of Reactive Robotics’ intelligent systems – now become the standard-of-care.

Since Reactive Robotics GmbH’s incorporation, the company has been on track. Prototype development, the establishment of a quality management system, and cooperation with business partners and suppliers is proceeding according to plan. On a regular basis, medical Key Opinion Leaders are consulted and care-taking experts are continuously involved in product development. Leading clinics are committed to supporting the clinical validation of the solution, and business development will be systematically established.

To keep up the pace in development and go-to-market, the existing investor consortium consisting of the lead investor MTIP MedTech Innovation Partners AG, High-Tech Gründerfonds, Bayern Kapital and TQ-Group, was extended by an additional lead investor: Dr. Doll Holding GmbH.

A seven-digit investment amount should enable Reactive Robotics to achieve the ambitious time plan and to accelerate the international market entry.

About Reactive Robotics GmbH

Reactive Robotics was founded in Munich, Germany, in April 2015 with the corporate objective to enable intensive care personnel to deliver the best possible Very Early Mobilization to intensive care patients. The team around the founder, Dr. Alexander Koenig, established TQ-Group, one of the leading Technology companies with broad robotics know-how, as its partner in July 2015. In May 2016, the company closed a series-A investment together with MTIP, High-Tech Gründerfonds, Bayern Kapital and TQ-Group.


Reactive Robotics GmbH
Dr. Alexander König
Landsberger Strasse 234 - 80687 München - Germany
Tel.: +49 89 54636278
Email: - twitter@Reactive-News -

About Dr. Doll Holding GmbH

Dr. Doll Holding GmbH, under the management of Dr. Theo Doll, holds shares in companies from the field of plastics technology (the Söhner Kunststofftechnik GmbH) and automation and robotics (the company Dr. Doll Engineering GmbH, IPR-Intelligente Peripherien für Roboter GmbH, Koris Vision und Force GmbH). All companies operate very successfully and are among the market leaders in their sector. Dr. Doll Holding GmbH invests in start-ups in the field of robotics and vision technology. Thanks to many years of development and production experience, including in the field of medical technology, Dr. Doll Holding GmbH can support start-ups strategically in the product development phase as well as in the establishment of series production.


Dr. Doll Holding GmbH
Dr. Theo Doll
Industriestraße 29 - 74193 Schwaigern - Germany
Tel.: +49 7138 812 200

About MTIP

MTIP is a Swiss-based venture capital investor specializing in the healthcare sector. Founded by entrepreneurs, our company partners with innovative start-ups in the medical device, diagnostic and digital health segments to create cost-effective and socially responsible solutions for improving patient care. Supported by seasoned investment professionals and a proprietary network of research institutions and medical facilities, we provide financial and strategic assistance from the startup through growth stages. Simply put, our goal is to empower talented entrepreneurs to develop successful and sustainable businesses with clear competitive advantages.


MTIP MedTech Innovation Partners AG
Dr. Christoph Kausch
Aeschenplatz 7 - 4052 Basel - Switzerland
Tel.: +41 61 551 02 50

About High-Tech Gruenderfonds

High-Tech Gründerfonds (HTGF) is Germany’s most active seed stage investor. With about EUR 820 million under management (EUR 272 million HTGF I, EUR 304 million HTGF II, EUR 245 million HTGFIII, 1. Closing), HTGF provide financing for technology-driven companies active in a wide range of fields, including robotics, IoT and energy, Medtech and Biotech, chemicals and software. The seed financing provided is designed to enable start-ups to take their ideas through prototyping and to market launch. HTGF can provide up to EUR 3 million in total financing per company in follow-on financing rounds. Furthermore, start-ups benefit from HTGF’s team experience and expertise as well as the extensive network of investors, experts, managers and scouts. Investors in this public-private partnership include the German Federal Ministry of Economics and Energy, the KfW, Fraunhofer-Gesellschaft e.V. and numerous strategic corporate investors, including ALTANA, BASF, B.Braun, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Drillisch AG, EVONIK, Haniel, Hettich, Knauf, Körber, Lanxess, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik and WACKER.


High-Tech Gründerfonds Management GmbH
Marco Winzer
Schlegelstraße 2 - 53113 Bonn - Germany
Tel.: +49 228 823001-06
Fax: +49 228 823000-50

About Bayern Kapital

Bayern Kapital GmbH, based in Landshut, was founded on the initiative of the Bavarian government in 1995. It is a wholly-owned subsidiary of the Bavarian LfA Förderbank. As the venture capital organization of the state of Bavaria, Bayern Kapital provides equity capital financing for the founders of young innovative technology companies in Bavaria.

Presently Bayern Kapital manages eleven investment funds with a total volume of around EUR 340 m. So far, it has over EUR 254 m in more than 250 innovative companies in the fields of technology in various sectors including life science, software & IT, medical technology, materials and new materials, nanotechnology and environmental technology.

In this way, almost 5000 long-term jobs in sustainable companies have been created in Bavaria.


Dr. Reinhard Saller
Schlegelstraße 2 - 53113 Bonn - Germany
Tel.: +49 89 2000 30-30

About TQ

As an electronics service provider (E²MS supplier and CEM) TQ offers the complete range of services from development, through production and service right up to product life cycle management. The services cover assemblies, equipment and systems including hardware, software and mechanics. Customers can obtain all services from TQ on a modular basis as individual services and also as a complete package according to their individual requirements. Standard products such as finished microcontroller modules (minimodules), drive and automation solutions complete the range of services.

Through the combination of electronics services and finished system components, TQ offers customerspecific products as ODM products and thereby addresses customers who would like to receive finished products and at the same time benefit from the advantages of a customer-specific solution. ODM products are provided on time and economically using a comprehensive solution kit. The kit includes finished electronic, mechanical and software components including certification and licenses.

The TQ Group employs approx. 1,400 colleagues at their 13 sites (11 x Germany, 1 x Switzerland, 1 x China).


TQ-Systems GmbH
Petra Zimmermann
Mühlstraße 2 – 82229 Seefeld - Germany
Tel.: +49 8153 9308-245



Stay updated with our newsletter.


Please feel free to contact us with any inquiry you might have.